Abstract:This study examines the policy determinants of bank default risk, proxied by credit default swap (CDS) spreads, using quarterly data from the U.S. and Canada for the period 2020 to 2022. The analysis considers four determinant groups: the COVID-19 pandemic shock, aggressive monetary and fiscal policy responses, macroprudential-related bank financial fundamentals, and macroeconomic and market conditions. Utilizing General Least Squares (GLS) and dynamic panel models with system General Method of Moments (GMM), the findings reveal that rising COVID-19 deaths significantly widen CDS spreads. Expansionary monetary policies reduce bank default risk, though the effectiveness under conventional monetary policy is reduced by increasing COVID-19 deaths. In contrast, expansionary fiscal policies and inflation broaden CDS spreads. The combined analysis highlights policy stances as dominant factors, with macroprudential-related fundamentals having minimal impact. The findings are robust using both 5-year and 10-year CDS measures. This study has significant policy implications during health and economic crises. For financial stability, policymakers should prioritize reducing pandemic-related deaths, utilize expansionary monetary policies with health support strategies, balance fiscal support to avoid excessive government spending, and implement measures to control inflation. It is essential to enhance coordination between healthcare, fiscal, and monetary authorities for effective policy implementation.

Debt rollover risk, credit default swap spread and stock returns: Evidence from the COVID-19 crisis

Supply chain risks and the cost of debt: Evidence from the COVID-19 pandemic

COVID-19 and Corporate Finance

COVID-19 Pandemic and Global Corporate CDS Spreads

Identifying policy determinants of bank default risk during the COVID-19 pandemic: empirical evidence from the U.S. and Canada

The COVID-19 pandemic, consumption and sovereign credit risk: Cross-country evidence

Margin purchases, short sales and stock return volatility in China: Evidence from the COVID-19 outbreak

Firm-level short selling and the local COVID-19 pandemic: Evidence from China

Pandemic shock, debt maturity structure and corporate performance

COVID-19 and instability of stock market performance: evidence from the U.S.

COVID-19 and financial market response in China: Micro evidence and possible mechanisms

The impact of COVID‐19 on supply chain credit risk

Rollover Risk and Credit Spreads in the Financial Crisis of 2008

Corporate Financial Measures and Covid-19 Pandemic with Evidence from the Growth Enterprise Market of China’s Shenzhen Stock Exchange

Credit Derivatives and Stock Return Synchronicity

International stock market risk contagion during the COVID-19 pandemic

The effects of heterogeneous CSR on corporate stock performance: evidence from COVID-19 pandemic in China

Impact of CSR on stock return resilience during the 2020 public health emergency: Evidence from the Chinese financial market

Rethinking capital structure decision and corporate social responsibility in response to COVID‐19

Corporate immunity to the COVID-19 pandemic

Studying corporate liquidity and regulatory responses for economic recovery in COVID-19 crises